ReviewPublished 26 November 2025Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a reviewJoan D’souza · Mukesh Nandave · Ruth BlöchlingerFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1609455
Science archivePublished 9 July 2025Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in JapanHidehisa Saeki · Makiko Usami · Katsuhisa Suzuki · Michika Mochizuki · Kazuhiko ArimaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14794
